Display options
Cite
Jouneau S, Brinchault G, Desrues B. Prise en charge des exacerbations: de la ville à l'hôpital. [Management of COPD exacerbations: from primary care to hospitalization]. Presse Med. 2014;43(12):1359-67doi: 10.1016/j.lpm.2014.03.034.
Jouneau, S., Brinchault, G., & Desrues, B. (2014). Prise en charge des exacerbations: de la ville à l'hôpital. [Management of COPD exacerbations: from primary care to hospitalization]. Presse medicale (Paris, France : 1983), 43(12), 1359-67. https://doi.org/10.1016/j.lpm.2014.03.034
Jouneau, Stéphane, et al. "Prise en charge des exacerbations: de la ville à l'hôpital." [Management of COPD exacerbations: from primary care to hospitalization]. Presse medicale (Paris, France : 1983) vol. 43,12 (2014): 1359-67. doi: https://doi.org/10.1016/j.lpm.2014.03.034
Jouneau S, Brinchault G, Desrues B. Prise en charge des exacerbations: de la ville à l'hôpital. [Management of COPD exacerbations: from primary care to hospitalization]. Presse Med. 2014 Dec;43(12):1359-67. doi: 10.1016/j.lpm.2014.03.034. Epub 2014 Oct 23. French. PMID: 25451635; PMCID: PMC7118899.
Copy Download .nbib Format: NLM
Share it on

Presse Med. 2014 Dec;43(12):1359-67. doi: 10.1016/j.lpm.2014.03.034. Epub 2014 Oct 23.

[Management of COPD exacerbations: from primary care to hospitalization].

Presse medicale (Paris, France : 1983)

[Article in French]
Stéphane Jouneau, Graziella Brinchault, Benoît Desrues

Affiliations

  1. Hôpital Pontchaillou, université de Rennes 1, service de pneumologie, 35033 Rennes, France; IRSET UMR 1085, université de Rennes 1, 35065 Rennes, France. Electronic address: [email protected].
  2. Hôpital Pontchaillou, université de Rennes 1, service de pneumologie, 35033 Rennes, France.

PMID: 25451635 PMCID: PMC7118899 DOI: 10.1016/j.lpm.2014.03.034

Abstract

The Société de pneumologie de langue française defines acute exacerbation of chronic obstructive pulmonary disease (AE COPD) as an increase in daily respiratory symptoms, basically duration ≥ 48h or need for treatment adjustment. Etiology of EA COPD are mainly infectious, viral (rhinovirus, influenzae or parainfluenzae virus, coronavirus, adenovirus and respiratory syncytial virus) or bacterial (Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis). Pollutant exposure can also lead to AE COPD, such as NO2, SO2, ozone or particulates (PM10 and PM2.5). In 30% the etiology remains unknown. Differential diagnoses of AE COPD include infectious pneumonia, pneumothorax, acute heart failure and pulmonary embolism. Presences of signs of severity impose hospitalization: signs of respiratory distress, shock, acute confusion but also fragile patients, insufficient home support or absence of response to initial treatment. AE COPD treatments consist on increase in bronchodilators, chest physiotherapy, and antibiotics if sputum is frankly purulent. Systemic corticosteroids should not be systematic. Recommended dose is 0.5 mg/kg on short course (5-7 days). During hospitalization, oxygen supplementation and thromboprophylaxis could be prescribed. The main interest in non-invasive ventilation is persistent hypercapnia despite optimal medical management. During ambulatory management or hospitalization, clinical assessment at 48-72 h is mandatory.

Copyright © 2014 Elsevier Masson SAS. All rights reserved.

References

  1. Lancet Infect Dis. 2001 Sep;1(2):101-14 - PubMed
  2. Eur Respir Rev. 2013 Dec;22(130):454-75 - PubMed
  3. Eur Respir J. 1999 Oct;14(4):934-9 - PubMed
  4. Ann Intern Med. 1987 Feb;106(2):196-204 - PubMed
  5. Cochrane Database Syst Rev. 2002;(4):CD003900 - PubMed
  6. BMJ. 2013 Oct 17;347:f6070 - PubMed
  7. PLoS One. 2012;7(5):e37483 - PubMed
  8. N Engl J Med. 2002 Aug 15;347(7):465-71 - PubMed
  9. Eur Respir J. 2013 Oct;42(4):946-55 - PubMed
  10. Cochrane Database Syst Rev. 2012 May 16;(5):CD003573 - PubMed
  11. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):407-12 - PubMed
  12. Respirology. 2007 Jan;12(1):81-7 - PubMed
  13. Respir Med. 2014 Mar;108(3):453-62 - PubMed
  14. Lancet. 2007 Sep 1;370(9589):786-96 - PubMed
  15. N Engl J Med. 2010 Sep 16;363(12):1128-38 - PubMed
  16. Rev Mal Respir. 2010 May;27(5):522-48 - PubMed
  17. Chest. 2002 May;121(5 Suppl):136S-141S - PubMed
  18. Eur Respir J. 2011 Sep;38(3):702-12 - PubMed
  19. Lancet. 2004 Feb 21;363(9409):600-7 - PubMed
  20. Respir Care. 2001 Aug;46(8):798-825 - PubMed
  21. Ann Intern Med. 2006 Mar 21;144(6):390-6 - PubMed
  22. BMJ. 2004 Aug 7;329(7461):315 - PubMed
  23. Telemed J E Health. 2012 Dec;18(10):772-6 - PubMed
  24. N Engl J Med. 1999 Jun 24;340(25):1941-7 - PubMed
  25. Eur Respir J. 2012 Jun;39(6):1354-60 - PubMed
  26. JAMA. 2013 Jun 5;309(21):2223-31 - PubMed
  27. Rev Mal Respir. 2012 May;29(5):637-9 - PubMed
  28. Lancet. 2001 Feb 17;357(9255):526-8 - PubMed
  29. Ann Intern Med. 2003 Jun 3;138(11):861-70 - PubMed
  30. N Engl J Med. 1999 Jul 22;341(4):233-9 - PubMed
  31. Rev Mal Respir. 2003 Jun;20(3 Pt 2):S65-8 - PubMed
  32. Eur Respir J. 2009 Nov;34(5):1072-8 - PubMed
  33. BMC Med. 2013 Aug 14;11:181 - PubMed
  34. PLoS Med. 2006 Nov;3(11):e442 - PubMed
  35. BMC Health Serv Res. 2013 Mar 06;13:82 - PubMed
  36. Rev Mal Respir. 2003 Jun;20(3 Pt 2):S56-64 - PubMed
  37. Am J Respir Crit Care Med. 2008 Apr 15;177(8):853-60 - PubMed
  38. N Engl J Med. 2003 Jun 26;348(26):2618-25 - PubMed
  39. Eur Respir J Suppl. 2003 Nov;47:31s-37s - PubMed
  40. Lancet. 1999 Aug 7;354(9177):456-60 - PubMed
  41. J Infect Dis. 2009 Aug 1;200(3):390-8 - PubMed
  42. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1298-303 - PubMed
  43. Eur Respir J. 2001 Jul;18(1):228-42 - PubMed
  44. Chest. 2007 Jan;131(1):9-19 - PubMed

MeSH terms

Publication Types